Oxford GlycoSciences plc Company Profile

23:54 EDT 25th September 2017 | BioPortfolio

OGS' drug discovery and development business has grown through our industrial proteomics technology experience coupled with our investment in core areas of research excellence such as glycobiology and glycochemistry.

Based on this combination of platform and drug discovery and development expertise and complemented by key alliances with high-profile companies, OGS has built ambitious programmes to discover new drugs in the areas of cancer, infectious disease and glycolipid storage disorders (GLSDs). By implementing our 'platform to product' vision, we believe our pipeline is poised for expansion in 2002 and beyond.


10 The Quadrant Barton Lane
OX14 3YS
United Kingdom


Phone: 44 1235 543200
Fax: 44 1235 554701

News Articles [317 Associated News Articles listed on BioPortfolio]

New light on the secret life of badgers

(University of Oxford) Badgers are more sociable than often thought, with implications for how they transmit disease, new Oxford University research reveals. Using security tracking technology more co...

#jobs #lifescience Immunocore: Early Diagnostic Senior Scientist – Oxford

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Immunocore: Early Diagnostic Senior Scientist – Oxford . Competitive sa...

Oxford Synbio Startup with Eyes on Therapeutics gets hold of CRISPR

Synbio startup Oxford Genetics has licensed CRISPR from Emmanuelle Charpentier’s company, ERS Genomics, to boost its platform. Synthetic biology has so far remained on the fringe of biotech, but...

Oxford Genetics Secures ??7.5 Million Investment

21st August 2017, Oxford Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has announced a 7.5 million investment into it...

Oxford researchers develop new scan to predict stroke

Researchers at the University of Oxford, supported by the NIHR Oxford Biomedical Research Centre, have developed a new type of MRI scan to predict the risk of having a stroke. The non-invasive techniq...

Event showcases Oxford’s role in cutting-edge medical technology

Some of the latest breakthroughs in precision medicine and digital health that are transforming patient care – many of them developed in Oxford – have been in the spotlight at an event held on...

Oxford Biomedica Announces Major Supply Agreement

NewsThis amount includes a $10 million upfront payment, various performance incentives and bioprocessing and development services.

The last survivors on Earth

(University of Oxford) The world's most indestructible species, the tardigrade, an eight-legged micro-animal, also known as the water bear, will survive until the sun dies, according to a new Oxford U...

Drugs and Medications [0 Results]


PubMed Articles [610 Associated PubMed Articles listed on BioPortfolio]

The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.

The Oxford Classification for Immunoglobulin A nephropathy (IgAN) identifies pathological variables that may predict the decline of renal function. This study aimed to evaluate the Oxford Classificati...

Book Reviews Pharmacology and Therapeutics of Asthma and COPD Edited by Clive P Page , Peter J Barnes Springer 2017 Price £278.50. Pp 285 ISBN 978 3 319 52173 2 Oxford Handbook of Infectious Diseases and Microbiology ( 2nd edn ) Estee Torok , Ed Moran , Fiona Cooke Oxford University Press 2016 Price £34.99. Pp 879 ISBN 978 0 19 9671328 Anaesthesia for the Elderly Patient ( 2nd edn ) Chris Dodds

Five-year clinical and radiological outcomes in 257 consecutive cementless Oxford medial unicompartmental knee arthroplasties.

Our aim was to examine the clinical and radiographic outcomes in 257 consecutive Oxford unicompartmental knee arthroplasties (OUKAs) (238 patients), five years post-operatively.

poRe GUIs for parallel and real-time processing of MinION sequence data.

Oxford Nanopore's MinION device has matured rapidly and is now capable of producing over one million reads and several gigabases of sequence data per run. The nature of the MinION output requires new ...

Book Reviews Ultrasound Edited by Leslie M Scoutt , Ulrike M Hamper , Teresita L Angtuaco Oxford University Press 2017 Price £112.50 . Pp 696 ISBN 978 0 19 998810 5 Geriatric Rehabilitation: From Bedside to Curbside K Rao Poduri CRC Press 2017 Price £140 . Pp 678 ISBN 978 1 48221 122 1 Challenging Concepts in Respiratory Medicine Edited by Lucy Schomberg , Elizabeth Sage , Nicholas Hart Oxford U

Clinical Trials [70 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

A Clinical Investigation of the Oxford® Partial Knee System

The purpose of this prospective data collection is to document the performance and clinical outcomes of the Oxford® Partial Knee System.

Companies [97 Associated Companies listed on BioPortfolio]

Oxford Resource Partners, LP

Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fir...

Oxford GlycoSciences plc

OGS' drug discovery and development business has grown through our industrial proteomics technology experience coupled with our investment in core areas of research excellence such as glycobiology and...


PROZYME® is a manufacturer of specialty PROteins and enZYMEs for diagnostics and research applications. All bulk products are also available in research quantities. Feel free to browse our Web Catal...

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...

Oxford Lasers, Inc.

Since 1977, Oxford Lasers has been supplying laser solutions to science and industry. Oxford Lasers was founded in 1977 by physicists from Oxford University whose research had been directed towards th...

More Information about "Oxford GlycoSciences plc" on BioPortfolio

We have published hundreds of Oxford GlycoSciences plc news stories on BioPortfolio along with dozens of Oxford GlycoSciences plc Clinical Trials and PubMed Articles about Oxford GlycoSciences plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford GlycoSciences plc Companies in our database. You can also find out about relevant Oxford GlycoSciences plc Drugs and Medications on this site too.

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record